Royal Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1
| Closed | – | – | 470 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 690 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 684 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 646 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 636 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 654 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 635 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 627 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 621 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 661 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 684 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 510 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 502 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 462 |
|
|
2016
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 408 |
|